J&J cuts 80 execs from middle ranks in India
Johnson & Johnson's Indian operations has laid off 80 middle managers since January as part of a global, companywide restructuring, India's Economic Times reports. Report
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Latest Commentary
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What's your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- Recipharm secures financing for future growth
- PPD Names David Simmons Chairman and CEO
- Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
- PPD Names David Simmons Chairman and CEO
- NICE recommends new treatment option for people with common heart condition
- More Press Releases
Featured Jobs
-
Associate Director, Manufacturing Operations Job
Celgene Corporation - Basking Ridge, NJ, US -
Regulatory Scientist Assistant III (Senior) Job
Yoh - Kenilworth, NJ, USA -
Clinical Research Associate / CRA Virology Job
Yoh - Danbury, CT, USA -
Director, Public Relations Job
Celgene Corporation - Summit, NJ, US -
Director, Pharmacovigilance and Drug Safety
TESARO - Waltham, MA
Comments